Mirum Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in ...
Mirum Pharma receives Health Canada authorization for maralixibat to treat cholestatic pruritus in patients with Alagille syndrome: Toronto Saturday, February 7, 2026, 15:00 Hrs [ ...
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...
Piramal Pharma Solutions has introduced a tablet-in-capsule drug delivery system at its drug product facilities in Pithampur and Ahmedabad, India.
The nutraceutical excipients market is projected to rise from USD 4.98 billion in 2025 to USD 7.12 billion by 2030, expanding ...
This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilitiesThe ...
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg (USRLD: Farxiga Tablets, 5 mg and 10 mg).
The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.
1dOpinion
The cost of a tablet
Exploring the vital link between healthcare costs and patient affordability in India's evolving medical landscape.
Noxafil indications have been expanded in Europe to include broader pediatric use, with age-, weight-, and formulation-specific recommendations.
Ayurveda is transitioning from tradition to evidence, driven by policy, science, and innovation. With global recognition, clinical trials, standardised extracts, and AI-guided research, ancient remedi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results